Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fluorescent In Situ Hybridization (FISH)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A Fluorescent In Situ Hybridization (FISH) technology. The Fish is a type of hybridization in which a DNA probe is labeled with fluorescent dye so that it can be seen with a microscope. It is use on the prenatal diagnosis of congenital disorders.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare
Acquirer
China Medical Technologies
Primary Office
  • British Virgin Islands

Fluorescent In Situ Hybridization (FISH) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Fluorescent In Situ Hybridization (FISH)‘s full profile, request access.

Request full access to PitchBook

Fluorescent In Situ Hybridization (FISH) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Fluorescent In Situ Hybridization (FISH)‘s full profile, request access.

Request full access to PitchBook